Acta oto-laryngologica · 2026
Clinical efficacy and prognostic factors of endoscopic surgery for chronic suppurative otitis media: a retrospective cohort study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Hao, Wang A Heng, Wu Yu, Xia Zhengping
Аннотация
BACKGROUND: Chronic suppurative otitis media (CSOM) is a significant global health concern, leading to persistent ear discharge and hearing loss.
AIMS/OBJECTIVES: This study aimed to evaluate the clinical efficacy and safety of EES for CSOM and to identify independent prognostic factors influencing surgical success.
MATERIALS AND METHODS: In this single-center retrospective cohort study, 180 patients undergoing EES for CSOM between 2022 and 2024 were enrolled. Data on demographics, clinical profiles, and surgical details were collected. Primary outcomes included dry ear rate, pure-tone average (PTA) improvement, and complications at 6 months post-surgery.
RESULTS: The 6-month dry ear rate was 91.1%. Mean PTA improved significantly by 24.8 ± 7.2 dB. The complication rate was 3.9%. Multivariate analysis identified cholesteatoma (HR = 3.24, 95% CI: 1.85-5.68, p < 0.001), disease duration >5 years (HR = 2.52, 95% CI: 1.45-4.38, p = 0.001), and preoperative PTA >50 dB (HR = 2.89, 95% CI: 1.65-5.06, p < 0.001) as independent risk factors for failure. Subgroup analyses confirmed the consistency of these factors.
CONCLUSIONS AND SIGNIFICANCE: Endoscopic ear surgery is an effective and safe treatment for CSOM in the mid-term (6-month) follow-up. Cholesteatoma, prolonged disease duration, and severe preoperative hearing loss are robust predictors of poorer outcomes.
AIMS/OBJECTIVES: This study aimed to evaluate the clinical efficacy and safety of EES for CSOM and to identify independent prognostic factors influencing surgical success.
MATERIALS AND METHODS: In this single-center retrospective cohort study, 180 patients undergoing EES for CSOM between 2022 and 2024 were enrolled. Data on demographics, clinical profiles, and surgical details were collected. Primary outcomes included dry ear rate, pure-tone average (PTA) improvement, and complications at 6 months post-surgery.
RESULTS: The 6-month dry ear rate was 91.1%. Mean PTA improved significantly by 24.8 ± 7.2 dB. The complication rate was 3.9%. Multivariate analysis identified cholesteatoma (HR = 3.24, 95% CI: 1.85-5.68, p < 0.001), disease duration >5 years (HR = 2.52, 95% CI: 1.45-4.38, p = 0.001), and preoperative PTA >50 dB (HR = 2.89, 95% CI: 1.65-5.06, p < 0.001) as independent risk factors for failure. Subgroup analyses confirmed the consistency of these factors.
CONCLUSIONS AND SIGNIFICANCE: Endoscopic ear surgery is an effective and safe treatment for CSOM in the mid-term (6-month) follow-up. Cholesteatoma, prolonged disease duration, and severe preoperative hearing loss are robust predictors of poorer outcomes.